This is a question we’ve contemplated quite a bit recently in preparing for last week’s Stop Reacting, Start Proacting webinar. (BTW, if you missed the live event, you can buy the video.) We’ve blogged some about our two-phase process for making good technology commercialization decisions via rapid screenings and market-based assessments of intellectual property (IP). But given the plethora of terminology that tech transfer offices (TTOs) and others in the industry use to name their evaluation and/or prioritization processes, I feel it’s important to be crystal clear. Because sometimes the same term can be used to describe two very different things, creating the classic apples-to-oranges comparisons. Continue reading →